61 results
8-K
EX-1.1
STRO
Sutro Biopharma Inc
2 Apr 24
Entry into a Material Definitive Agreement
5:10pm
Effect. The Company takes reasonable measures to ensure that such information is protected against unauthorized access, use, modification, or other misuse … are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain accountability for assets; (iii) access
8-K
EX-1.1
STRO
Sutro Biopharma Inc
9 Feb 24
Other Events
4:27pm
. The Company takes reasonable measures to ensure that such information is protected against unauthorized access, use, modification, or other misuse … with GAAP and to maintain accountability for assets; (iii)
access to assets is permitted only in accordance with management’s general or specific
8-K
EX-99.1
qld gtrnc0z4uhk
13 Nov 23
Sutro Biopharma Reports Third Quarter 2023 Financial Results, Business Highlights and Select Anticipated Milestones
4:30pm
8-K
EX-99.1
ry235elag 3n
10 Aug 23
Sutro Biopharma Reports Second Quarter 2023 Financial Results, Business Highlights and Select Anticipated Milestones
4:31pm
8-K
EX-99.1
o2a7yt
15 May 23
Sutro Biopharma Reports First Quarter 2023 Financial Results, Business Highlights and Select Anticipated Milestones
8:01am
PRE 14A
62wf3b5nqrsm3 0nk9
14 Apr 23
Preliminary proxy
4:05pm
8-K
EX-99.1
rezr44f
30 Mar 23
Sutro Biopharma Reports Full Year 2022 Financial Results, Business Highlights and Select Anticipated Milestones
4:32pm
8-K
EX-99.1
m0a8if49mocz
8 Nov 22
Sutro Biopharma Reports Third Quarter 2022 Financial Results, Business Highlights and Select Anticipated Milestones
4:31pm